Work Here?
Overview
Rho is a contract research organization that provides end-to-end development and regulatory services for drugs, biologics, and medical devices. Clients range from small biotech startups to large pharma, relying on Rho to plan and run clinical development, regulatory strategy, and submissions for NDAs, BLAs, and MAAs. The company supports decentralized clinical trials and infectious-disease programs, offering integrated expertise across study design, data management, and regulatory affairs. Its goal is to help clients bring products to market efficiently by navigating regulatory requirements and streamlining development and submission processes.
About Rho
Industries
Consulting
Biotechnology
Healthcare
Company Size
501-1,000
Company Stage
N/A
Total Funding
N/A
Headquarters
Durham, North Carolina
Founded
1984
Get referred to Rho
See people who can refer or advise you
Simplify's Take
What believers are saying
- Sharp’s July 2025 engagement extends Rho into rare-disease development and submission work.
- Tonix’s February 2024 NDA engagement validates Rho’s value in late-stage regulatory execution.
- Rho’s news page updated March 16, 2026 signals active business development and current operations.
What critics are saying
- Biotech funding drought hits Rho’s small-client base; Sharp and Tonix depend on capital markets.
- Rho’s recent public visibility is thin; no 2025-2026 flagship contract announcement surfaced.
- Large CROs like IQVIA and PPD compress pricing, squeezing Rho’s mid-market positioning.
What makes Rho unique
- Rho’s 1984 heritage and RTP base anchor deep regulatory and clinical expertise.
- Tonix chose Rho in February 2024 for NDA submission support.
- Sharp Therapeutics hired Rho in July 2025 for Gaucher IND preparation.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Remote Work Options
Flexible Work Hours
Growth & Insights and Company News
6 month growth
↑ 6%1 year growth
↑ 6%2 year growth
↑ 6%Rho Appoints Peter Schmidt, Ph.D., as SVP, Government Partnerships, Executive Committee Member Research Triangle Park, NC – April 19, 2022 – Rho, a global full-service contract research organization (CRO) with a proven track record of drug development success, has appointed Peter Schmidt, Ph.D., as Senior Vice President, Government Partnerships of Rho’s Federal Systems Division.
Ms. Gladwell was appointed as COO of Rho in May 2021.
Research Triangle Park, NC – January 12, 2022 – Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, has promoted Mark Ubert, MBA, to the position of Chief Financial Officer (CFO).
Rho is Hiring for 8 Jobs on Simplify!
Find jobs on Simplify and start your career today
About Rho
Industries
Consulting
Biotechnology
Healthcare
Company Size
501-1,000
Company Stage
N/A
Total Funding
N/A
Headquarters
Durham, North Carolina
Founded
1984
Rho is Hiring for 8 Jobs on Simplify!
Find jobs on Simplify and start your career today